Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
ABP-671 by Jiangsu Atom Bioscience and Pharmaceutical for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
ABP-671 is under clinical development by Jiangsu Atom Bioscience and Pharmaceutical and currently in Phase I for Chronic Kidney Disease...
Data Insights
ABP-671 by Jiangsu Atom Bioscience and Pharmaceutical for Gouty Arthritis (Gout): Likelihood of Approval
ABP-671 is under clinical development by Jiangsu Atom Bioscience and Pharmaceutical and currently in Phase III for Gouty Arthritis (Gout)....